While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers ...

Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of ...

Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in ...

The FDA derives just under half of its yearly funding from pharma user fees, which help support its operations and fund ...

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

The FDA approved Amgen ’s anti-CD19 therapy Uplizna Thursday for use in patients with IgG4-related disease. Uplizna is the ...

The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...

The European Medicines Agency asked for three clinical trials to be placed on hold until the exact cause of death of a US ...

Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational ...

An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...

The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.

Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector ...